Inactivation of adenovirus type 5 by caustics

Biotechnology Progress

Volumn 21, Issue 2, 2005, Pages 446-450

  Jannat, Risat ^a   Hsu, David ^a,b   Maheshwari, Gargi ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORROSION PROTECTION; DECONTAMINATION; GENES; PH EFFECTS; SODIUM COMPOUNDS; STAINLESS STEEL;

ADENOVIRUS; CROSS PRODUCT CONTAMINATION; LARGE SCALE PRODUCTION; THERAPEUTIC GENES;

VIRUSES;

HYDROXIDE; POTASSIUM DERIVATIVE; POTASSIUM HYDROXIDE; SODIUM HYDROXIDE;

ADENOVIRUS; ARTICLE; DRUG EFFECT; GENETICS; PH; POLYMERASE CHAIN REACTION; VIRUS INACTIVATION;

ADENOVIRIDAE; HYDROGEN-ION CONCENTRATION; HYDROXIDES; POLYMERASE CHAIN REACTION; POTASSIUM COMPOUNDS; SODIUM HYDROXIDE; VIRUS INACTIVATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 16344380117     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp049812f     Document Type: Article

References (18)

1. Borovec, S.; Broumis, C.; Adcock, W.; Fang, R.; Uren, E. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat. Biologicals 1998, 26 (3), 237-44.
2. Boschetti, N.; Wyss, K.; Mischler, A.; Hostettler, T.; Kempf, C. Stability of minute virus of mice against temperature and sodium hydroxide. Biologicals 2003, 31 (3), 181-5.
3. Crathorn, A. R.; Shooter, K. V. The alkaline hydrolysis of phosphotriesters in alkylated mammalian DNA. Biochim Biophys. Acta 1982, 697 (2), 259-61.
4. Derbyshire, J. B.; Arkell, S. The activity of some chemical disinfectants against Talfan virus and porcine adenovirus type 2. Br. Vet. J. 1971, 127 (5), 137-42.
5. Derbyshire, J. B.; Brown, E. G. The inactivation of viruses in cattle and pig slurry by aeration or treatment with calcium hydroxide. J. Hyg. (London) 1979, 82 (2), 293-9.
6. Gulich, S.; Linhult, M.; Stahl, S.; Hober, S. Engineering streptococcal protein G for increased alkaline stability. Protein Eng. 2002, 15 (10), 835-42.
7. Jooss, K.; Chirmule, N. Immunity to adenovirus and adenoassociated viral vectors: implications for gene therapy. Gene Ther. 2003, 10 (11), 955-63.
8. Lancz, G. J. Effect of pH on the kinetics of herpes simplex virus inactivation at 36 degrees. Virology 1976, 75 (2), 488-91.
9. Lewis, J.; Wang, F.; Harper, C.; Louis, A.; McMackin, J.; Mathis, W. C.; Hager, A.; Schofield, T. The QPA Assay: The Use of QPCR to Assay Infectious Potency of Adenovirus Preparations; American Society of Gene Therapy, 4th annual meeting, Seattle, WA, 2001.
10. Limbach, K. J.; Paoletti, E. Nonreplicating expression vectors: applications in vaccine development and gene therapy. Epidemiol. Infect. 1996, 116 (3), 241-56.
11. Luff, P. R. Control of manufacture-principles and purposes. Dev. Biol. Stand. 1992, 79, 155-8.
12. Maheshwari, G.; Jannat, R.; McCormick, L.; Hsu, D. Thermal inactivation of adenovirus type 5. J. Virol. Methods 2004, 118(2), 141-6.
13. Michelson, S.; Schofield, T. The Biostatistics Cookbook: The Most User-Friendly Guide for the Bio/medical Scientist; Kluwer Academic Publishers: Boston, 1996.
14. Shooter, K. V. The kinetics of the alkaline hydrolysis of phosphotriesters in DNA. Chem. Biol. Interact. 1976, 13 (2), 151-63.
15. Sofer, G. Validation of biotechnology products and processes. Curr. Opin. Biotechnol. 1995, 6(2), 230-4.
16. Sofer, G. Virus inactivation in the 1990s-and into the 21st century: Part 3a, Plasma and plasma products (heat and solvent/detergent treatments). BioPharm 2003, 15 (9), 28-42.
17. Ye, K.; Dhiman, H. K.; Suhan, J.; Schultz, J. S. Effect of pH on infectivity and morphology of ecotropic moloney murine leukemia virus. Biotechnol. Prog. 2003, 19 (2), 538-43.
18. Zhang, W. W. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther. 1999, 6 (2), 113-38.